![Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy](https://www.frontiersin.org/files/Articles/708784/fonc-11-708784-HTML-r1/image_m/fonc-11-708784-t002.jpg)
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
![Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation | Blood Cancer Journal Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0269-6/MediaObjects/41408_2019_269_Fig1_HTML.png)
Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation | Blood Cancer Journal
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry | PLOS ONE
![Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy](https://www.frontiersin.org/files/Articles/708784/fonc-11-708784-HTML-r1/image_m/fonc-11-708784-g001.jpg)
Frontiers | An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy
![Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 - Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 -](https://onlinelibrary.wiley.com/cms/asset/2a17aff5-3df2-4f0d-b745-5142e9a2172c/ajh25973-fig-0002-m.jpg)
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy - Mir - 2020 -
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy | Haematologica
![Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/3b562fcd-5f44-4b2a-94ba-e685e9f1a1c5/gr1.jpg)
Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting - Annals of Oncology
![Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet](https://www.thelancet.com/cms/attachment/2113983484/2084460292/gr1.gif)
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry - The Lancet
![PDF) {"__content__"=>"A simplified scoring system in follicular lymphoma treated initially with immunochemotherapy.", "i"=>{"__content__"=>"de novo"}} | Alain Delmer - Academia.edu PDF) {"__content__"=>"A simplified scoring system in follicular lymphoma treated initially with immunochemotherapy.", "i"=>{"__content__"=>"de novo"}} | Alain Delmer - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/81624723/mini_magick20220302-2658-kele74.png?1646293205)
PDF) {"__content__"=>"A simplified scoring system in follicular lymphoma treated initially with immunochemotherapy.", "i"=>{"__content__"=>"de novo"}} | Alain Delmer - Academia.edu
![A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120321029-fx1.jpg)
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect
![Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram](https://www.researchgate.net/publication/51535872/figure/fig3/AS:305826607714311@1449926153958/Outcome-and-risk-of-lymphoma-progression-according-a-risk-groups-as-defined-by-FLIPI-2.png)
Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram
![A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120321029-gr1.jpg)
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy - ScienceDirect
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://www.mdpi.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g002b.png)
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
![Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project | Journal of Clinical Oncology Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2009/jco.2009.23.27.issue-27/jco.2008.21.3991/20161107/images/small/zlj9990989190001.gif)
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project | Journal of Clinical Oncology
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://www.mdpi.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g003.png)
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
![Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt download Workshop With the Experts: Overcoming Barriers to Optimal Treatment of Non-Hodgkin's Lymphoma Jointly sponsored by Annenberg Center for Health Sciences. - ppt download](https://images.slideplayer.com/39/10946845/slides/slide_19.jpg)